Active Ingredient (In Each 15 Ml Dose)
Bismuth subsalicylate 262 mg
The following Structured Product Label (SPL) was submitted to the FDA by Kesin Pharma for the product Bismuth Subsalicylate (NDC 81033-046). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each 15 ml dose), purpose, uses, warnings, do not use if you have, ask a doctor before use if you have, ask a doctor or pharmacist before use, otc - when using, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Bismuth subsalicylate 262 mg
Upset stomach reliever and antidiarrheal
Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Allergy alert: Contains salicylate. Do not take if you are
if you are taking any drug for
When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur
If pregnant or breast-feeding, ask a health professional before use.
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
NDC 81033-046-15: 15 mL unit-dose cup
NDC 81033-046-34: Carton containing 30 unit-dose cups of 15 mL each
anhydrous citric acid, benzoic acid, D&C Red #22, D&C Red #28, flavor, purified water, salicylic acid, sodium citrate, sodium
salicylate, sorbic acid, sucralose, xanthan gum.
Call 1-833-537-4679
*This product is not manufactured or distributed by The Procter and Gamble Company. Pepto-Bismol® is a registered
trademark of The Procter and Gamble Company.
Distributed by:
Kesin Pharma
Oldsmar, FL 34677
PIS-046-V01
Rev. 08/2026
* Please review the disclaimer below.